http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-246540-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3bfedd8ba4800708cecfd357707f8f67
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-32
filingDate 1986-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_348d9e5cfcca10de4cdddd6f3d16f882
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0c5dd37f36ba4c5036e9ac04e93af96
publicationDate 1987-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DD-246540-A1
titleOfInvention PROCESS FOR PREPARING 1-SUBSTITUTED 3-CARBOXYALKYLOXY-PYRAZOLIN-5-ONEN
abstract The invention has the aim of obtaining the title compounds and their salts in high yields in a technically very simple manner. The previously unknown title compounds and their physiologically acceptable salts serve as antiphlogistics and antisclerogenic cardiovascular drugs. The object is achieved according to the invention by means of a hitherto unknown, surprisingly simple synthesis principle, namely the simultaneous introduction of a carbonyl function in the 5-position and a bromo substituent in the 4-position of the pyrazole ring of 1-substituted 3-carboxyalkyloxy-pyrazoles in an aqueous-alkaline medium at reaction temperatures around 20C by means of bromine and optionally the reductive replacement of the 4-bromo substituent by hydrogen in an aqueous-alkaline medium at reaction temperatures around 20C using inexpensive technical reducing agents, for example sodium sulfite.
priorityDate 1986-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71387754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508577
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407126721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54057899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428408340
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455695671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24489
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7751
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409092530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449013851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415855234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22174802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12199811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394777
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423444585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425997307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453719388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394736
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3704386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416115865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID155150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411860674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450108871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413965066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1268256
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834

Total number of triples: 49.